Community Psychosis Risk Screening: An Instrument Development Investigation
dc.contributor.author | Ellman, Lauren M. | |
dc.contributor.author | Schiffman, Jason | |
dc.contributor.author | Mittal, Vijay A. | |
dc.date.accessioned | 2020-10-06T17:38:37Z | |
dc.date.available | 2020-10-06T17:38:37Z | |
dc.date.issued | 2020-08-20 | |
dc.description.abstract | Schizophrenia and other psychotic disorders are serious psychiatric disorders that are associated with substantial societal, family, and individual costs/distress. Evidence suggests that early intervention can improve prognostic outcomes; therefore, it is essential to accurately identify those at risk for psychosis before full psychotic symptoms emerge. The purpose of our study is to develop a brief, valid screening questionnaire to identify individuals at risk for psychosis in non-clinical populations across 3 large, community catchment areas with diverse populations. This is a needed study, as the current screening tools for at-risk psychotic populations in the US have been validated only in clinical and/or treatment seeking samples, which are not likely to generalize beyond these specialized settings. The specific aims are as follows: (1) to determine norms and prevalence rates of attenuated positive psychotic symptoms across 3 diverse, community catchment areas and (2) to develop a screening questionnaire, inclusive of both symptom-based and risk factor-based questions. Our study will develop an essential screening tool that will identify which individuals have the greatest need of follow-up with structured interviews in both research and clinical settings. Our study has the potential for major contributions to the early detection and prevention of psychotic disorders. | en_US |
dc.description.sponsorship | We would like to thank Evan Calvo, Alexis Cruz, and Raana Mohyee for their helpful edits on this manuscript. We also would like to thank our teams at Temple, UMBC, and Northwestern for continuing to contribute ideas to this project and for their enormous help carrying out the study aims. Finally, our NIMH program officers (first Dr. Stacia Friedman-Hill and now Dr. Sarah Morris) have been and continue to offer invaluable support and advice, which made this project possible. | en_US |
dc.description.uri | http://jpbs.hapres.com/htmls/JPBS_1292_Detail.html | en_US |
dc.format.extent | 39 pages | en_US |
dc.genre | journal articles | en_US |
dc.identifier | doi:10.13016/m21zpc-kddz | |
dc.identifier.citation | Lauren M. Ellman, Jason Schiffman and Vijay A. Mittal, Community Psychosis Risk Screening: An Instrument Development Investigation, J Psychiatry Brain Sci. 2020;5:e200019. https://doi.org/10.20900/jpbs.20200019 | en_US |
dc.identifier.uri | https://doi.org/10.20900/jpbs.20200019 | |
dc.identifier.uri | http://hdl.handle.net/11603/19730 | |
dc.language.iso | en_US | en_US |
dc.publisher | Hapres | en_US |
dc.relation.isAvailableAt | The University of Maryland, Baltimore County (UMBC) | |
dc.relation.ispartof | UMBC Psychology Department Collection | |
dc.relation.ispartof | UMBC Faculty Collection | |
dc.rights | This item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author. | |
dc.rights | Attribution 4.0 International | * |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | * |
dc.title | Community Psychosis Risk Screening: An Instrument Development Investigation | en_US |
dc.type | Text | en_US |